Study directory

ADHD studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1740studies shown
Showing 133-144 of 1,740
Drug study icon
Enrolling By InvitationNCT05301361

Sensitivity of the NIH Toolbox to Stimulant Treatment in Intellectual Disabilities

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Sacramento
Why is this study shown?

This study is directly about ADHD.

ADHDDrugA study involving a medication or substance.From 6 Years to 24 Years
Countries
United States
Sponsor
University of California, Davis
Condition
ADHD
Drug study icon
Recruitment unclearEUCTR 2017-001490-16

Lisdexamphetamine treatment of Bulimia Nervosa with and without probable simultaneous Attention Deficit Hyperactivity Disorder (ADHD). A randomized , open, fase II-study with cross-over design.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Sweden
Why is this study shown?

This study is directly about ADHD.

ADHD, Eating disordersDrug
Countries
Sweden
Sponsor
Stockholms läns landsting
Condition
ADHD, Eating disorders
Other study type icon
Not recruitingISRCTN71988966

A parenting programme for Japanese mothers of children at risk of attention deficit hyperactivity disorder (ADHD)

This study is looking at whether a parenting support programme can help people with Attention deficit hyperactivity disorder, Mental and Behavioural Disorders, or Hyperkinetic disorders. Participants take part in a parenting support programme and complete follow-up assessments.

In Japan
Why is this study shown?

This study is directly about ADHD.

ADHDOther
Countries
Japan
Sponsor
Okinawa Institute of Science and Technology Graduate Univers
Condition
ADHD
Behavioral study icon
Not recruitingISRCTN13460510

Nurturing Brazilian babies’ early social and communication development in families with history of autism and attention-deficit/hyperactivity disorder (ADHD)

This study is looking at whether psychoeducation can help people with Support of early social-communication development in infants aged 6-11 months with family history of autism and attention-deficit/hyperactivity disorder or Mental and Behavioural Disorders. Participants take part in psychoeducation and complete follow-up assessments.

In Brazil
Why is this study shown?

This study is directly about ADHD.

ADHDOther
Countries
Brazil
Sponsor
Universidade de São Paulo
Condition
ADHD
Drug study icon
Not recruitingISRCTN76063113

The INCA study: a study into the Impact of Nutrition on Children with Attention-Deficit Hyperactivity Disorder (ADHD)

This study is testing a medication approach for people with Attention-deficit hyperactivity disorder, Mental and Behavioural Disorders, or Disturbance of activity and attention. Participants receive a study treatment and complete follow-up visits and assessments.

In Netherlands
Why is this study shown?

This study is directly about ADHD.

ADHDOther
Countries
Netherlands
Sponsor
Wageningen University (The Netherlands)
Condition
ADHD
Behavioral study icon
RecruitingNCT06906328

MEthylphenidate for ADHD

The registry lists this study as recruiting. Study locations are listed in France.

In Nantes
Why is this study shown?

This study is directly about ADHD.

ADHD, AddictionBehavioralFrom 18 Years to 99 Years
Countries
France
Sponsor
Nantes University Hospital
Condition
ADHD, Addiction
Other study type icon
Not Yet RecruitingNCT06594536

Efficacy of Sulforaphane for ADHD

This study is not yet recruiting. It is testing efficacy of Sulforaphane for ADHD.

Location not clearly listed
Why is this study shown?

This study is directly about ADHD.

ADHDOtherFrom 6 Years to 12 Years
Countries
Sponsor
Assistance Publique - Hôpitaux de Paris
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.